| Financial Year |
March 31 2023 |
| Monetary Funds |
3,225,006,349.06 |
| Held-for-trading Financial Assets |
198,410,424.76 |
| Notes Receivable |
2,000,000.00 |
| Accounts Receivable |
1,127,484,945.30 |
| Advances to Suppliers |
352,453,450.01 |
| Other Receivables |
130,228,774.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,427,364,199.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
27,405,324.11 |
| Other Current Assets |
340,868,919.94 |
| Total Current Assets |
6,831,222,387.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
404,414,353.69 |
| Long-term Equity Investment |
2,526,331,806.52 |
| Investment Properties |
-- |
| Fixed Assetes |
333,105,463.12 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
132,328,092.24 |
| R&D expenses |
316,087,884.08 |
| Goodwill |
271,854,051.92 |
| Long-Term Deferred and Prepaid Expenses |
243,978,483.92 |
| Deferred Income Tax Assets |
1,170,018,497.75 |
| Other Non-Current Assets |
713,219,267.71 |
| Sub-Total of Non-Current Assets |
9,288,683,663.23 |
| Total Assets |
16,119,906,050.83 |
| Short-Term Loans |
450,921,583.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
291,216,242.75 |
| Accounts Received In Advance |
336,923,904.34 |
| Employee Compensation Payable |
386,291,272.34 |
| Taxes Payable |
240,310,216.02 |
| Interest Payable |
-- |
| Dividend Payable |
175.64 |
| Other payables |
353,153,471.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
165,666,401.81 |
| Other Current Liabilities |
28,618,302.35 |
| Sub-Total of Current Liabilities |
4,014,890,060.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
503,630,880.27 |
| Other Non-Current Liabilities |
14,020,995.55 |
| Sub-Total of Non-Current Liabilities |
2,442,792,757.89 |
| Total Liabilities |
6,457,682,818.24 |
| Paid-In Capital(Or Share Stock) |
2,011,661,461.00 |
| Capital Surplus |
1,690,085,656.73 |
| Surplus Reserve |
788,948,844.81 |
| LESS:Treasury Stock |
505,370,403.76 |
| Undistributed Profits |
5,644,168,616.06 |
| Minority Stockholder's Interest |
293,903,742.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,368,319,490.41 |
| Owner's Equity（Stockholder's Equity） |
9,662,223,232.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,119,906,050.83 |
